This document discusses broad spectrum antibiotics tetracyclines and chloramphenicol. It provides details on tetracyclines including their classification, mechanism of action, antimicrobial spectrum, pharmacokinetics, therapeutic uses and adverse effects. A new class of synthetic tetracycline analogues called glycylcyclines is also described, with focus on tigecycline. The document briefly mentions chloramphenicol but does not provide any details.
This document discusses broad spectrum antibiotics tetracyclines and chloramphenicol. It provides details on tetracyclines including their classification, mechanism of action, antimicrobial spectrum, pharmacokinetics, therapeutic uses and adverse effects. A new class of synthetic tetracycline analogues called glycylcyclines is also described, with focus on tigecycline. The document briefly mentions chloramphenicol but does not provide any details.
This document discusses broad spectrum antibiotics tetracyclines and chloramphenicol. It provides details on tetracyclines including their classification, mechanism of action, antimicrobial spectrum, pharmacokinetics, therapeutic uses and adverse effects. A new class of synthetic tetracycline analogues called glycylcyclines is also described, with focus on tigecycline. The document briefly mentions chloramphenicol but does not provide any details.
Figure : Bacterial protein synthesis and the sites of action of antibiotics
Mechanism of Action of Tetracyclines Primarily bacteriostatic. Inhibit protein synthesis in the susceptible microbes as follows: Bind to the 30S ribosomes in the susceptible microbes → Block the attachment of aminoacyl-t-RNA aminoacyl to the acceptor (A) site of mRNA-ribosome mRNA complex → Peptide chain fails to grow → Protein synthesis is inhibited. Antimicrobial Spectrum of Tetracyclines Gram + ve Cocci: Some strains of: • Streptococcus pyogenes • Staphylococcus aureus (including MRSA) • Enterococci. Gram - ve Cocci: Some strains of: • Neisseria gonorrhoeae • Neisseria meningitidis (Minocycline may still have Significant activity against these cocci) Gram + ve bacilli: Clostridia & other anaerobes, Corynebacteria, Propionibacterium acnes, Bacillus anthracis, Listeria, Mycobacterium leprae (only to minocycline). Gram - ve bacilli: H. ducreyi, C. granulomatis, V. cholerae, Y. pestis, Y. enterocolitica, C. jejuni, Brucella, P. multocida, F. tularensis & many anaerobes. Spirochaetes: Treponema pallidum, Borrelia (relapsing fever) Rickettsiae (typhus etc): All are highly sensitive. Chlamydiae: All are highly sensitive. Mycoplasma: Moderately sensitive. Actinomyces: Moderately sensitive. Protozoa: (Inhibited at high conc). • Entamoeba histolytica, Plasmodia. Pharmacokinetics of tetracyclines • Older tetra: Incomplete absorption from GIT. • Doxycycline & Minocycline: Complete absorption (irrespective of food). • Chelating property: Bind with calcium & other metals thereby forming insoluble & unabsorbable complexes: Avoid / stagger the concurrent administration with milk, iron, non-systemic systemic antacids, sucralfate etc. • Bind to the connective tissue in the bones & teeth. • Minocycline: highly lipid soluble. Accumulates in the body fat. • Low CSF concentrations: (even during meningeal inflammation). • Dose reduction needed in renal failure: (except doxycycline). • Secreted in milk: may affect the suckling infant. • Oral capsule: Most preferred dosage form. • Doxycycline: Most commonly used tetracycline (100 mg / once or twice daily). Therapeutic uses of tetracyclines I) Drugs of first choice in: in 1. Venereal diseases:
Typhus Q fever Rocky mountain spotted fever. 3. Atypical pneumonia: Mycoplasma pneumoniae: ↓ Duration of illness. Chlamydia psittaci (Ornithosis/Parrot fever): Two weeks therapy is needed. 4. Cholera: ↓ Stool volume & DuraEon of diarrhoea. 5. Brucellosis: (Malta /Mediterranean/ Undulant fever): Doxycycline 200 mg/day + Rifampicin 600 mg/day for 6 weeks (+ Gentamicin in acute cases) Highly effective Rapid symptomatic relief. 6. Plague: Mass Rx of suspected cases in epidemic. Effective in both bubonic & pneumonic plague. 7. Relapsing fever: (d/t: Borrelia recurrentis). II) As Second choice drugs in: in Conditions Second choice to: Tetanus, Anthrax, Penicillin /Ampicillin Actinomycosis, Listeriosis. Gonorrhoea (in the patients Ceftriaxone/Amoxycillin/ allergic to penicillin) Azithromycin Syphilis (in the patients allergic Ceftriaxone to penicillin) Leptospirosis Penicillin (Doxy 100 mg BD X 7 days). III) Other situations in which tetracyclines are used: used • UTI: Odd cases if sensitive. • Community Acquired Pneumonia: Pneumonia If a selective antibiotic can’t be used. • Chronic intestinal amoebiasis: amoebiasis With other amoebicides. • Chloroquine-resistant resistant P. falciparum malaria: malaria As adjuvant to Quinine / Artesunate. • Acne vulgaris: Prolonged therapy with low doses. IV) As empirical therapy: therapy If the nature & sensitivity of infecting microorganism is not known. Initial Rx of mixed infections. Unreliable as empirical treatment of serious / life threatening infections. Adverse effects of Tetracyclines 1. Teeth & Bones: Tetracyclines have chelating property Calcium-tetracycline tetracycline chelate gets deposited in the developing teeth & bones. If given from midpregnancy to 5 months of age,deciduous teeth are affected resulting in: → Brown discolouration, ill formed teeth & ↑ suscepEbility to dental caries. • Given between 3 months to 6 years of age: → Damage to the crown of permanent anterior dentition. • Given during late pregnancy or childhood: → Temporary suppression of bone growth. 2. Phototoxicity: Sunburn like severe skin reaction on exposed parts Higher incidence with Demeclocycline & Doxycycline. 3. Superinfections: • Occur commonly as tetracyclines cause marked suppression of the resident flora. • Intestinal superinfection by Candida albicans is most prominent. • More liability of Candidial diarrhoea d/t incomplete absorption in the ileum. • Pseudomembranous enterocolitis (Clostridium difficile) (Rare but serious). • Overgrowth of Pseudomonas & Proteus in the bowel. 4. Liver damage: • Fatty infiltration of liver & jaundice occasionally. • Given during pregnancy: → may precipitate fatal acute hepatic necrosis. 5. Kidney damage: (esp. in patients with kidney disease): • Worsening of renal failure (except doxycycline). • Fanconi syndrome-like like condition due to the use of outdated & degraded tetracyclines (cause damage to the proximal tubules). 6. Irritative effects: • Irritant property of tetracyclines can cause: → Epigastric pain, nausea, vomiting & diarrhoea. • Accidental release of the material from capsule into the oesophagus during swallowing: → Odynophagia (pain while swallowing) → oesophageal ulceration • Thrombophlebitis of the injected vein. 7. Vestibular toxicity: Minocycline can cause: Ataxia, vertigo & nystagmus. Subside on discontinuation. 8. Antianabolic effect: ↓ Protein synthesis - ve nitrogen balance ↑ Blood urea 9. Diabetes insipidus: Demeclocycline antagonizes ADH acEon & ↓ urine concentraEng ability of the kidneys. 10. ↑ ICT: noted in some infants. Glycylcyclines A new class of synthetic tetracycline analogues. Active against most of the bacteria that have developed resistance to the classical tetracyclines: Have the broadest spectrum of activity. Tigecycline • First glycylcycline (2005). • Derivative of minocycline. • Active against most of the gram + ve & gram – ve cocci as well as anaerobes (Tetra sensitive & resistant). Pharmacokinetics of Tigecycline: Tigecycline • Poor absorption on oral administration. • Given by slow IV infusion (only). • Wide tissue distribution. • Long DOA: (Elimination t1/2 : 36-60 hours). MOA of Tigecycline: Same as tetracyclines. Dose: 100 mg loading dose, followed by 50 mg BD by IV infusion over 30-60 30 min, for 5-14 days. No cross-resistance resistance with tetracyclines because: because Tetracycline efflux pumps have low affinity for Tigecycline. Bacterial ribosomal protection protein against tetracycline has less capacity to protect the ribosomal binding site from tigecycline. Approved therapeutic uses of Tigecycline: Tigecycline • Serious & hospitalized patients of community acquired pneumonia. • Complicated skin & skin structure infections • Complicated intra-abdominal abdominal infections (caused by Enterococci, Anaerobes & Enterobacteriaceae). Chloramphenicol Chloramphenicol Broad spectrum antibiotic. Initially obtained from Streptomyces venezuelae, now entirely synthetic. Antibacterial activity d/t its nitrobenzene moiety. Primarily bacteriostatic action. Mechanism of action: Inhibition of bacterial protein synthesis: 1. 2. 3. 4. Aminoglycosides Tetracyclines Chloramphenicol Macrolides
Figure : Bacterial protein synthesis and the sites of action of antibiotics
MOA of chloramphenicol Attaches to the 50S ribosome near the acceptor (A) site of the ribosome-mRNA mRNA complex → Interferes with the transfer of elongating (nascent) peptide chain from the peptidyl (P) site to the at the acceptor (A) site (that has the newly attached aminoacyl tRNA) → Prevents the peptide bond formation between the nascent peptide chain & the newly attached amino acid → Inhibits the bacterial protein synthesis. Antimicrobial spectrum of chloramphenicol Broad spectrum antibiotic. Primarily bacteriostatic. Active against nearly the same range of microbes as tetracyclines. Notable differences between these: Chloramphenicol is more active & has cidal effect against H. influenzae & N. meningitidis (in high conc.) More active against B. pertussis & Klebsiella. Less active against gram + ve cocci & Spirochaetes. No inhibition of Entamoeba & Plasmodia. Therapeutic uses of chloramphenicol 1. Intraocular infections: Attains high conc. in the ocular fluid on systemic admn: Preferred drug for endophthalmitis caused by sensitive bacteria. 2. Topically: (0.5-5 %): Conjunctivitis External ear infections 3. As second line drug for: i) Pyogenic meningitis: (Bacterial meningitis): (DOC: Third gen. cephalosporins + Vancomycin) • Due to its excellent CSF penetration & proven efficacy, Chloramphenicol may be used as second line drug in: Haemophilus influenzae meningitis Meningococcal meningitis (N. meningitidis). ii) Anaerobic infections: (B. fragilis etc): (DOC: Clindamycin/Metronidazole + Penicillin/Cephalo) Wound infections Intraabdominal infections, Pelvic abscess Brain abscess. iii) Whooping cough: (As second choice to erythromycin). iv) Rickettsial infections & Brucellosis: Brucellosis (especially in young children & pregnant women, as tetracyclines are contraindicated in them). Adverse effects of chloramphenicol 1. Bone marrow depression: Amongst all antibiotics, Chloramphenicol is the most prominent cause of: Aplastic anaemia, Agranulocytosis, Thrombocytopenia & Pancytopenia. Two forms: i) Non-dose dose related idiosyncratic reaction: reaction Rare, unpredictable, fatal & based on genotype. Many victims, even if they survive, may develop leukaemias later on. ii) Dose & duration of therapy related: related Direct toxic effect, predictable, reversible & d/t inhibition of mitochondrial enzyme synthesis in the erythropoietic cells. Often reversible (No long-term long sequelae). 2. Gray baby syndrome: • D/t inability of the newborn to adequately metabolize & excrete chloramphenicol Avoid in neonates. 3. Hypersensitivity reactions: reactions Rashes, fever, atrophic glossitis, angioedema. 4. Irritative effects: Nausea, vomiting, diarrhoea, pain on inj. 5. Superinfections: Similar to tetracyclines, but less common. Thank You